{"nct_id":"NCT05180708","title":"A Multicenter, Phase 3 Randomized, Double-Blind, Vehicle-Controlled Study Evaluating the Safety and Efficacy of QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Pachyonychia Congenita","status":"COMPLETED","status_verified_date":"2024-08","start_date":"2021-11-29","start_date_type":"ACTUAL","primary_completion_date":"2023-06-30","primary_completion_date_type":"ACTUAL","completion_date":"2023-06-30","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["PVLA"]}